NEW YORK (GenomeWeb) – Thermo Fisher Scientific and Siemens Healthcare have announced a new strategic relationship to integrate Thermo Fisher's real-time PCR into Siemens' Versant kPCR molecular diagnostics platform.
The partners have already combined the technologies into a workflow that Siemens will display next week at the European Congress of Clinical Microbiology and Infectious Disease.
"We are excited to collaborate with Siemens in support of its Versant kPCR Molecular Solution as we work to expand our partnerships in the diagnostics space," Drew Burch, Thermo Fisher's head of licensing and commercial supply, said in a statement.
Thermo Fisher offers a real-time PCR ecosystem of reagents, instruments, and assays.
Siemens' Versant kPCR Molecular System has proved to be a platform upon which emerging infectious disease assays can be run. Last month, Siemens released a research-use-only Zika virus test, and in recent years other diagnostics firms have developed qPCR assays, such as a MERS test, that can run on Versant.